Role of BMPR2 expression in HPAH; implications for novel therapeutic approaches
BMPR2 表达在 HPAH 中的作用;
基本信息
- 批准号:8499398
- 负责人:
- 金额:$ 46.02万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-06-01 至 2016-05-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAffectAllelesAnxietyBioinformaticsClinicClinicalCollaborationsCollectionDataDatabasesDevelopmentDiagnosisDiagnosticDiseaseEmployee StrikesEtiologyFDA approvedGene Expression RegulationGenesGeneticGenomicsGoalsHaplotypesHumanIndividualInheritedLeadLinkLungMapsMeasurableMessenger RNAModelingMolecularMorbidity - disease rateMutateMutationNaturePathogenesisPathway interactionsPatientsPenetrancePharmaceutical PreparationsPhysiciansPhysiologicalPlayPredispositionPulmonary HypertensionQuantitative Trait LociRegulationResearchResearch PersonnelResourcesRiskRisk FactorsRoleScientistSymptomsTimeTransforming Growth FactorsUncertaintyUnited StatesVascular Endothelial Cellbasebone morphogenic proteindesigndisease diagnosisdisorder riskdrug candidateexpectationfollow-upgenetic risk factorhypertension treatmentimprovedinnovationinsightkindredknockout genemRNA Expressionmembermortalitymouse modelmutation carriernovelnovel therapeutic interventionoffspringpredictive modelingpublic health relevancepulmonary arterial hypertensionreceptorsmall hairpin RNAtherapeutic targettool
项目摘要
DESCRIPTION (provided by applicant): The long-term objective of this project is to better understand the role of genetic factors in the pathogenesis of pulmonary arterial hypertension (PAH), which is an autosomal dominant fatal disease. Mutations in the bone morphogenic protein receptor 2 (BMPR2) gene, a member of the transforming growth factor (TGF-2) superfamily, are found in the majority of cases of the heritable type of PAH (HPAH). A striking feature of HPAH is its incomplete penetrance-a majority of pathogenic mutation carriers (~80%) show no clinical symptoms but can produce offspring that are affected by HPAH. Thus a mutation carrier cannot predict whether he or she will develop clinical disease, creating anxiety on the mutation carrier's part and uncertainty as to treatment and follow up on the physician's part. Our proposal is designed to address this key issue in HPAH. Our data suggest a paradigm-shifting concept for HPAH pathogenesis-that expression levels of the wild-type (WT) non-mutated BMPR2 allele may be the primary determinant of disease penetrance in HPAH. This highlights the importance of BMPR2 expression in PAH pathogenesis and emphasizes the need for better understanding of mechanisms that control BMPR2 expression. Based on these data we hypothesize that disease is linked to the expression level of the WT BMPR2 allele in HPAH and total BMPR2 expression in idiopathic (I) PAH. The proposed research is a collaboration between geneticists, basic scientists, statisticians and pulmonologists and will produce a synergistic effect that is not easily matched by a single investigator. The rationale for the proposed research is that understanding the genetic mechanisms behind BMPR2 gene regulation could lead to better diagnosis and treatment options for HPAH. Our specific aims are as follows. 1. Determine the role of BMPR2 expression in disease penetrance in HPAH and as a risk factor in IPAH. 2. Determine the genomic and molecular basis of the observed variability in BMPR2 expression in HPAH and IPAH patients. 3. Identify potential new PAH treatments. This proposal is designed to be translational in nature. It presents an innovative paradigm that integrates clinical and genetic data and state of the art approaches such as quantitative trait locus mapping and the use of the Connectivity Map database to answer key unknowns in HPAH and uses that information to identify potential therapeutic targets. It is our expectation that we will: 1) develop a better understanding of the genetic factors that control BMPR2 expression; 2) develop a predictive model of disease that will have clinical diagnostic utility; and 3) identify new treatment options for PAH.
描述(申请人提供):这个项目的长期目标是更好地了解遗传因素在肺动脉高压(PAH)发病机制中的作用,PAH是一种常染色体显性遗传性致命疾病。骨形态发生蛋白受体2(BMPR2)基因是转化生长因子(TGF-2)超家族成员之一,在大多数遗传型PAH(HPAH)中发现突变。HPAH的一个显著特征是其不完全外显--大多数致病突变携带者(~80%)没有临床症状,但可以产生受HPAH影响的后代。因此,突变携带者无法预测他或她是否会发展为临床疾病,这给突变携带者带来了焦虑,也给医生的治疗和后续治疗带来了不确定性。我们的提案旨在解决HPAH中的这一关键问题。我们的数据提示了HPAH发病机制的一个范式转换概念--野生型(WT)非突变BMPR2等位基因的表达水平可能是HPAH疾病外显性的主要决定因素。这突出了BMPR2表达在PAH发病机制中的重要性,并强调了更好地了解控制BMPR2表达的机制的必要性。基于这些数据,我们假设疾病与WT BMPR2等位基因在HPAH中的表达水平和BMPR2在特发性(I)PAH中的总表达水平有关。这项拟议的研究是遗传学家、基础科学家、统计学家和肺病学家之间的合作,将产生单一研究人员难以比拟的协同效应。这项拟议研究的基本原理是,了解BMPR2基因调控背后的遗传机制可以为HPAH提供更好的诊断和治疗选择。我们的具体目标如下。1.确定BMPR2表达在HPAH的疾病外显性中的作用及其在IPAH中的危险因素。2.确定在HPAH和IPAH患者中观察到的BMPR2表达变异的基因组和分子基础。3.确定潜在的多环芳烃新疗法。这项提议的设计是为了翻译性质。它提出了一种创新的范式,整合了临床和遗传数据以及最新的方法,如定量性状基因座定位和使用连接图数据库来回答HPAH中的关键未知因素,并使用这些信息来确定潜在的治疗靶点。我们的期望是:1)更好地了解控制BMPR2表达的遗传因素;2)开发具有临床诊断实用价值的疾病预测模型;3)确定PAH的新治疗方案。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RIZWAN HAMID其他文献
RIZWAN HAMID的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RIZWAN HAMID', 18)}}的其他基金
Role of bone marrow cells in pathogenesis and therapy of heritable pulmonary arterial hypertension
骨髓细胞在遗传性肺动脉高压发病机制和治疗中的作用
- 批准号:
9289360 - 财政年份:2017
- 资助金额:
$ 46.02万 - 项目类别:
Vanderbilt Center for Undiagnosed Diseases (VCUD)
范德比尔特未确诊疾病中心 (VCUD)
- 批准号:
9301691 - 财政年份:2014
- 资助金额:
$ 46.02万 - 项目类别:
Role of BMPR2 expression in HPAH; implications for novel therapeutic approaches
BMPR2 表达在 HPAH 中的作用;
- 批准号:
8107380 - 财政年份:2011
- 资助金额:
$ 46.02万 - 项目类别:
Role of BMPR2 expression in HPAH; implications for novel therapeutic approaches
BMPR2 表达在 HPAH 中的作用;
- 批准号:
8264550 - 财政年份:2011
- 资助金额:
$ 46.02万 - 项目类别:
Role of BMPR2 expression in HPAH; implications for novel therapeutic approaches
BMPR2 表达在 HPAH 中的作用;
- 批准号:
8669802 - 财政年份:2011
- 资助金额:
$ 46.02万 - 项目类别:
Role of BMPR2 expression in HPAH; implications for novel therapeutic approaches
BMPR2 表达在 HPAH 中的作用;
- 批准号:
9285935 - 财政年份:2011
- 资助金额:
$ 46.02万 - 项目类别:
Functions of the TG-Interacting Transcription Factor (TGIF) in Hematopoiesis
TG 相互作用转录因子 (TGIF) 在造血中的功能
- 批准号:
7659770 - 财政年份:2009
- 资助金额:
$ 46.02万 - 项目类别:
Functions of the TG-Interacting Transcription Factor (TGIF) in Hematopoiesis
TG 相互作用转录因子 (TGIF) 在造血中的功能
- 批准号:
7920195 - 财政年份:2009
- 资助金额:
$ 46.02万 - 项目类别:
Functions of the TG-Interacting Transcription Factor (TGIF) in Hematopoiesis
TG 相互作用转录因子 (TGIF) 在造血中的功能
- 批准号:
8073026 - 财政年份:2009
- 资助金额:
$ 46.02万 - 项目类别:
相似海外基金
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
- 批准号:
2327346 - 财政年份:2024
- 资助金额:
$ 46.02万 - 项目类别:
Standard Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
- 批准号:
2312555 - 财政年份:2024
- 资助金额:
$ 46.02万 - 项目类别:
Standard Grant
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
- 批准号:
BB/Z514391/1 - 财政年份:2024
- 资助金额:
$ 46.02万 - 项目类别:
Training Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
- 批准号:
ES/Z502595/1 - 财政年份:2024
- 资助金额:
$ 46.02万 - 项目类别:
Fellowship
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
- 批准号:
23K24936 - 财政年份:2024
- 资助金额:
$ 46.02万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
- 批准号:
ES/Z000149/1 - 财政年份:2024
- 资助金额:
$ 46.02万 - 项目类别:
Research Grant
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
- 批准号:
2901648 - 财政年份:2024
- 资助金额:
$ 46.02万 - 项目类别:
Studentship
ERI: Developing a Trust-supporting Design Framework with Affect for Human-AI Collaboration
ERI:开发一个支持信任的设计框架,影响人类与人工智能的协作
- 批准号:
2301846 - 财政年份:2023
- 资助金额:
$ 46.02万 - 项目类别:
Standard Grant
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
- 批准号:
488039 - 财政年份:2023
- 资助金额:
$ 46.02万 - 项目类别:
Operating Grants
How motor impairments due to neurodegenerative diseases affect masticatory movements
神经退行性疾病引起的运动障碍如何影响咀嚼运动
- 批准号:
23K16076 - 财政年份:2023
- 资助金额:
$ 46.02万 - 项目类别:
Grant-in-Aid for Early-Career Scientists